|

naltrexone and bupropion (combination) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 4: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • GLP - 11
  • Schizo Affective Disorder1
  • Bipolar II Disorder1
  • Bipolar I Disorder1
  • Weight Loss1

Rochester, Minnesota1 trial

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

Mayo Clinic

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.